# #38–Francisco Gonzalez-Lima, Ph.D.: Alzheimer’s disease & the vascular hypothesis

**Channel:** Peter Attia MD
**Upload Date:** 2020-01-07
**URL:** https://www.youtube.com/watch?v=zCjMFuFv9Gg
**Duration:** 152 minutes

## Description

Original release date: 1/28/18

In this episode, Francisco Gonzalez-Lima, a Professor of Neuroscience and Pharmacology & Toxicology, explains the vascular hypothesis of Alzheimer’s disease which says the central problem is a progressive neuronal energy crisis of impaired blood flow to the brain and impaired mitochondrial respiration. He walks us through the ways we can intervene in this process and also shares details of the exciting future of Alzheimer’s treatment and prevention.

We discuss:
-Background and interest in the brain [5:15];
-The unique nature of the human brain [9:15];
-Why we’ve made so little progress in Alzheimer’s research [23:00];
-The amyloid beta hypothesis [28:30];
-Hypometabolism in the brain leading to cognitive decline [39:30];
-Early signs of AD, and deciphering between age-related decline versus something pathologic [47:45];
-The vascular hypothesis of Alzheimer’s disease [54:00];
-The relationship between mitochondria, cytochrome c oxidase, and Alzheimer’s disease [1:08:00];
-Chronic inhibition of cytochrome c oxidase leads to chronic neurodegenerative disease [1:22:45];
-Major risk factors for AD, head trauma, and other forms of dementia [1:33:45];
-Methylene blue for treating and preventing neurodegeneration [1:38:15];
-Current standard of care for AD, and the reasons for a lack of advancement [2:01:45];
-Near infrared light as a targeted treatment for cognitive decline [2:05:30];
-The ketogenic diet as a treatment and preventative measure [2:13:15];
-Exciting future research coming from Francisco [2:13:00];
-Methylene blue for traumatic brain injuries [2:25:15]; and
-More.

Show notes page: https://peterattiamd.com/franciscogonzalezlima/

About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. 

Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com/
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Play: http://bit.ly/TheDriveGooglePlay

## AI Summary

Here's my comprehensive analysis of this episode of The Drive podcast with Francisco Gonzalez-Lima:

1. **Executive Summary**:
This episode focuses on Alzheimer's disease (AD) and the vascular hypothesis, challenging the traditional amyloid-beta hypothesis. Dr. Gonzalez-Lima explains how late-onset Alzheimer's disease may primarily be a progressive neuronal energy crisis caused by impaired blood flow and mitochondrial respiration. The discussion covers potential preventive approaches including methylene blue, near-infrared light therapy, and metabolic interventions.

2. **Key Medical/Scientific Points**:
- Original Alzheimer's case from 1907 was likely early-onset disease, different from common late-onset AD [38:00]
- Cytochrome oxidase (Complex IV) is more inducible than other electron transport chain complexes [1:19:30]
- Brain consumes 20% of body's energy while being only 2% of body weight [55:16]
- Chronic hypoperfusion leads to approximately 20% decrease in brain blood supply between ages 22-60 [2:07:36]

3. **Health Optimization Tips**:

Universal Recommendations:
- Regular fasting periods (14-16 hours) to maintain ketogenic enzyme function [2:22:49]
- Blood pressure management below 120/80 [1:02:00]
- Cardiovascular health optimization benefits brain health [1:08:20]

Context-specific recommendations:
- Ketogenic diet may be particularly beneficial for brain function [2:18:09]
- Transcranial near-infrared light therapy targeting prefrontal cortex [2:07:36]

4. **Supplements & Medications**:

Methylene Blue:
- Low dose (1mg/kg) for neuroprotective effects [2:26:27]
- Different grades available (pharmaceutical grade recommended) [1:54:40]
- Can be administered orally or intravenously [1:37:00]

5. **Exercise & Movement**:
- Morning workout can help accelerate glucose utilization during fasting [2:22:49]

6. **Nutrition & Diet**:
- Ketogenic diet benefits for brain metabolism [2:18:09]
- Importance of periodic fasting [2:22:49]
- Mother's milk naturally contains medium-chain triglycerides [2:18:09]

7. **Biomarkers & Testing**:
- Near-infrared spectroscopy can measure oxidized cytochrome oxidase in vivo [2:24:50]
- Blood pressure monitoring [1:02:00]

8. **References & Resources**:
- Book: "Alzheimer's Turning Point" by Jack de la Torre [1:49:57]
- Multiple NIH grants mentioned for near-infrared research [2:24:50]

9. **Notable Quotes**:
"The amyloid-beta hypothesis is completely, absolutely false." [29:32]
"If you have a brain, you're at risk." [1:02:26]

10. **Follow-up Questions**:
- What is the optimal dosing protocol for methylene blue in prevention?
- How might combination therapy with methylene blue and near-infrared light work?
- What role might methylene blue play in acute traumatic brain injury?

Let me know if you would like me to expand on any of these sections.
